\-\ Texto\\:\\ \ \(0\)\
\-\ alert\\ and\\ oriented\\,\\ with\\ a\\ very\\ hypophonic\\ voice\\ with\\ short\\ one\\ word\\ answers\\.\\ \\ \\ \\ 5\\/5\\ strength\\ in\\ all\\ four\\ extremities\\.\\ reflexes\\ brisk\\ in\\ biceps\\,\\ and\\ knees\\.\\ \\ sensation\\ intact\\ throughout\\.\\ \\ \\ finger\\ to\\ nose\\ intact\\-\\ end\\ point\\ tremor\\,\\ mild\\ dysmetria\\,\\ heel\\ to\\ shin\\ with\\ mild\\ dysmetria\\.\\ gait\\ with\\ two\\ person\\ assist\\ was\\ unsteady\\ with\\ short\\ shuffling\\ steps\\,\\ but\\ after\\ a\\ few\\ steps\\,\\ he\\ remained\\ unsteady\\ but\\ progressed\\ towards\\ a\\ more\\ normal\\ stride\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ labs\\ were\\ significant\\ for\\:\ \(0\)\
\-\ ceruloplasmin\\ \\<6\\ mg\\/dl\ \(0\)\
\-\ copper\\ serum\\ low\\ \\ 34\\ mcg\\/dl\ \(0\)\
\-\ 24\\ hr\\ urine\\ copper\\ level\\ 182\\ mcg\\/day\ \(1\)\
\-\ a\\ liver\\ biopsy\\ showed\\ mild\\ to\\ moderate\\ fibrosis\\ \\(stage\\ 2\\)\\.\\ copper\\ in\\ the\\ liver\\ biopsy\\ paraffin\\ block\\ was\\ high\\ at\\ 350\\.9\\ mcg\\/g\\.\\ \ \(0\)\
\-\ the\\ patient\\ was\\ discharged\\ with\\ glycopyrrolate\\ 1mg\\ tid\\,\\ as\\ needed\\ for\\ drooling\\.\\ his\\ wilson\\'s\\ disease\\ was\\ treated\\ with\\ the\\ copper\\ chelator\\ trientine\\,\\ starting\\ dose\\ of\\ 250\\ mg\\ bid\\,\\ and\\ then\\ increased\\ to\\ 500\\ mg\\ bid\\.\\ the\\ patient\\ was\\ readmitted\\ to\\ the\\ hospital\\ 2\\ months\\ after\\ discharge\\ with\\ worsening\\ mental\\ status\\ and\\ muscle\\ spasms\\.\\ he\\ also\\ had\\ failure\\ to\\ thrive\\,\\ with\\ oropharyngeal\\ dysphagia\\,\\ becoming\\ tube\\ feed\\ dependent\\.\\ his\\ copper\\ serum\\ was\\ low\\ at\\ 17\\ mcg\\/dl\\,\\ and\\ his\\ ceruloplasmin\\ remained\\ low\\ at\\ \\<6\\ mg\\/dl\\.\\ his\\ trientine\\ dose\\ was\\ decreased\\,\\ and\\ a\\ trial\\ of\\ zinc\\ was\\ started\\.\\ no\\ interventions\\ appeared\\ to\\ be\\ helpful\\ in\\ \\ the\\ improvement\\ of\\ his\\ mental\\ status\\,\\ and\\ he\\ passed\\ away\\.\ \(0\)\
\-\ mri\\ of\\ the\\ brain\\ with\\ and\\ without\\ contrast\\:\ \(0\)\
\-\ there\\ is\\ abnormal\\ diffusion\\ restriction\\ with\\ associated\\ t2\\ and\\ flair\\ hyperintensity\\ involving\\ the\\ bilateral\\ thalami\\ with\\ extension\\ into\\ the\\ midbrain\\ and\\ pons\\ as\\ well\\ as\\ the\\ bilateral\\ putamina\\ in\\ a\\ symmetric\\ manner\\.\\ \\ additional\\ diffusion\\ restriction\\ abnormality\\ with\\ associated\\ t2\\ and\\ flair\\ hyperintensity\\ involves\\ the\\ cortex\\ of\\ the\\ bilateral\\ frontal\\ lobes\\,\\ left\\ greater\\ than\\ right\\.\\ \\ low\\ gradient\\ signal\\ is\\ seen\\ in\\ the\\ putamina\\ as\\ well\\.\\ there\\ is\\ no\\ mass\\ effect\\ associated\\ with\\ this\\ abnormal\\ signal\\.\\ no\\ other\\ abnormal\\ parenchymal\\ signal\\ is\\ identified\\.\\ diffuse\\ parenchymal\\ volume\\ loss\\ is\\ also\\ noted\\.\ \(0\)\
\-\ hepatolenticular\\ degeneration\\,\\ wilson\\'s\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ wilson\\'s\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ leigh\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ creutzfeldt\\ jakob\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ carbon\\ monoxide\\ poisoning\ \(0\)\
\-\ \\â\\€\\¢\\ hypoxic\\-ischemic\\ encephalopathy\ \(0\)\
\-\ \\â\\€\\¢\\ pkan\\/nbia\\ \\(hallervorden\\-spatz\\)\ \(0\)\
\-\ this\\ 21\\ y\\.o\\.\\ man\\ presents\\ with\\ several\\ months\\ of\\ progressive\\ apraxia\\,\\ sialorrhea\\,\\ decreased\\ appetite\\,\\ hesitant\\ gait\\,\\ and\\ recent\\ urinary\\ incontinence\\.\\ \\ previous\\ history\\ of\\ asperger\\â\\€\\™s\\ and\\ bipolar\\ affective\\ disorder\\.\ \(0\)\
\-\ this\\ is\\ a\\ classic\\ clinical\\ presentation\\ of\\ wilson\\'s\\ disease\\ that\\ included\\ low\\ cerulosplasmin\\,\\ dysarthria\\,\\ ataxia\\,\\ drooling\\,\\ and\\ urinary\\ incontinence\\.\\ \\ an\\ ocular\\ slit\\-lamp\\ examination\\ was\\ done\\ on\\ this\\ patient\\,\\ but\\ it\\ was\\ not\\ revealing\\ of\\ kayser\\-fleischer\\ rings\\.\\ \ \(0\)\
\-\ youtube\\ \\-\\ http\\:\\/\\/www\\.youtube\\.com\\/watch\\?v\\=p9cmy7gowxw\\&\ \(0\)\
\-\ the\\ classic\\ mri\\ findings\\ found\\ in\\ this\\ patient\\ include\\ bilateral\\,\\ symmetric\\ t2wi\\ hyperintensity\\ of\\ the\\ putamina\\,\\ \\'face\\ of\\ a\\ giant\\ panda\\'\\ in\\ the\\ midbrain\\,\\ and\\ \\'face\\ of\\ a\\ miniature\\ panda\\'\\ in\\ the\\ pontine\\ tegmentum\\.\\ \\ cortical\\ white\\ matter\\ changes\\ have\\ been\\ previously\\ reported\\ in\\ this\\ disease\\ process\\ as\\ well\\,\\ which\\ are\\ seen\\ in\\ the\\ bilateral\\ frontal\\ lobes\\ of\\ this\\ patient\\.\\ \ \(0\)\
\-\ review\\ \\-\\ pmid\\:\\ 15205951\ \(0\)\
\-\ lab\\ diagnosis\\ \\-\\ pmid\\:\\ 18568852\ \(0\)\
\-\ practical\\ approach\\ \\-\\ pmid\\:\\ 17382611\ \(0\)\
\-\ copper\\ \\&\\ iron\\ overload\\ patterns\\ pmid\\:\\ 23338780\ \(0\)\
\-\ references\\:\\ \ \(0\)\
\-\ jacobs\\ da\\,\\ markowitz\\ ce\\,\\ liebeskind\\ ds\\,\\ galetta\\ sl\\.\\ the\\ double\\ panda\\ sign\\ in\\ wilson\\â\\€\\™s\\ disease\\.\\ neurology\\.\\ 2003\\;61\\:969\\.\ \(0\)\
\-\ king\\ ad\\,\\ walshe\\ jm\\,\\ kendall\\ be\\,\\ chinn\\ rj\\,\\ paley\\ mn\\,\\ wilkinson\\ id\\,\\ et\\ al\\.\\ cranial\\ mr\\ imaging\\ in\\ wilson\\â\\€\\™s\\ disease\\.\\ ajr\\ am\\ j\\ roentgenol\\.\\ 1996\\;167\\:1579\\-84\\.\\ \ \(0\)\
\-\ singh\\ p\\,\\ ahluwalia\\ a\\,\\ saggar\\ k\\,\\ grewal\\ cs\\.\\ wilson\\â\\€\\™s\\ disease\\:\\ mri\\ features\\.\\ j\\ pediatr\\ neurosci\\ 2011\\;6\\:27\\-28\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ copper\\:\\ 0\\.29186981635401227\ \(0\)\
\-\ wilson\\:\\ 0\\.28349000603640134\ \(0\)\
\-\ putamina\\:\\ 0\\.16591593193030962\ \(0\)\
\-\ panda\\:\\ 0\\.1533093095375324\ \(0\)\
\-\ pmid\\:\\ 0\\.1518128269103688\ \(0\)\
\-\ disease\\:\\ 0\\.14516600624538892\ \(0\)\
\-\ the\\:\\ 0\\.13110963900288752\ \(0\)\
\-\ mg\\:\\ 0\\.1207501613317573\ \(0\)\
\-\ was\\:\\ 0\\.1205242306900817\ \(0\)\
\-\ in\\:\\ 0\\.11183978464638063\ \(0\)\
\-\ ceruloplasmin\\:\\ 0\\.11061062128687309\ \(0\)\
\-\ trientine\\:\\ 0\\.11061062128687309\ \(0\)\
\-\ and\\:\\ 0\\.107191459982285\ \(0\)\
\-\ his\\:\\ 0\\.10486795409969439\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.10346024978557225\ \(0\)\
\-\ with\\:\\ 0\\.10157595715345191\ \(0\)\
\-\ low\\:\\ 0\\.0992187826560178\ \(0\)\
\-\ steps\\:\\ 0\\.09380179142983681\ \(0\)\
\-\ bilateral\\:\\ 0\\.09293017063337464\ \(0\)\
\-\ dysmetria\\:\\ 0\\.09237367121098658\ \(0\)\
\-\ of\\:\\ 0\\.0879799282135152\ \(0\)\
\-\ drooling\\:\\ 0\\.08791500540616479\ \(0\)\
\-\ bid\\:\\ 0\\.08701644567028329\ \(0\)\
\-\ unsteady\\:\\ 0\\.08539737650131868\ \(0\)\
\-\ this\\:\\ 0\\.08318273670708919\ \(0\)\
\-\ restriction\\:\\ 0\\.08153612254701012\ \(0\)\
\-\ youtube\\:\\ 0\\.08099714458182897\ \(0\)\
\-\ midbrain\\:\\ 0\\.07699296157280054\ \(0\)\
\-\ incontinence\\:\\ 0\\.07313170761849198\ \(0\)\
\-\ as\\:\\ 0\\.0694655458200484\ \(0\)\
\-\ remained\\:\\ 0\\.06840055826254775\ \(0\)\
\-\ dose\\:\\ 0\\.06459028549507326\ \(0\)\
\-\ abnormal\\:\\ 0\\.06233051959862534\ \(0\)\
\-\ parenchymal\\:\\ 0\\.06213240683727357\ \(0\)\
\-\ serum\\:\\ 0\\.062021675403393095\ \(0\)\
\-\ he\\:\\ 0\\.06143587146138468\ \(0\)\
\-\ to\\:\\ 0\\.060519298363100674\ \(0\)\
\-\ mental\\:\\ 0\\.060279230303177125\ \(0\)\
\-\ gait\\:\\ 0\\.059903230942687034\ \(0\)\
\-\ urinary\\:\\ 0\\.05981102511628966\ \(0\)\
\-\ short\\:\\ 0\\.0594490577070693\ \(0\)\
\-\ symmetric\\:\\ 0\\.0592720471511085\ \(0\)\
\-\ flair\\:\\ 0\\.05884050666630181\ \(0\)\
\-\ mild\\:\\ 0\\.05881189570256504\ \(0\)\
\-\ signal\\:\\ 0\\.05881189570256504\ \(0\)\
\-\ diffusion\\:\\ 0\\.05826104449743671\ \(0\)\
\-\ lobes\\:\\ 0\\.05770801669552828\ \(0\)\
\-\ is\\:\\ 0\\.05682428999518976\ \(0\)\
\-\ patient\\:\\ 0\\.05624012651861134\ \(0\)\
\-\ hypophonic\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ glycopyrrolate\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ chelator\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ hepatolenticular\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ sialorrhea\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ affective\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ cerulosplasmin\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ miniature\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ tegmentum\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ 15205951\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ 18568852\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ 17382611\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ 23338780\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ markowitz\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ liebeskind\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ galetta\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ walshe\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ kendall\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ chinn\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ ahluwalia\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ saggar\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ grewal\\:\\ 0\\.055305310643436544\ \(0\)\
\-\ associated\\:\\ 0\\.05468307290224596\ \(0\)\
\-\ mri\\:\\ 0\\.05325511197233748\ \(0\)\
\-\ stride\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ paraffin\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ zinc\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ asperger\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ paley\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ wilkinson\\:\\ 0\\.05284717685659445\ \(0\)\
\-\ classic\\:\\ 0\\.051732445742034915\ \(0\)\
\-\ but\\:\\ 0\\.05130363900659536\ \(0\)\
\-\ shuffling\\:\\ 0\\.05110310317917747\ \(0\)\
\-\ hesitant\\:\\ 0\\.05110310317917747\ \(0\)\
\-\ ce\\:\\ 0\\.05110310317917747\ \(0\)\
\-\ king\\:\\ 0\\.05110310317917747\ \(0\)\
\-\ neurosci\\:\\ 0\\.05110310317917747\ \(0\)\
\-\ well\\:\\ 0\\.050235382028770224\ \(0\)\
\-\ intact\\:\\ 0\\.05006041600857408\ \(0\)\
\-\ answers\\:\\ 0\\.0497502945358871\ \(0\)\
\-\ apraxia\\:\\ 0\\.0497502945358871\ \(0\)\
\-\ ds\\:\\ 0\\.0497502945358871\ \(0\)\
\-\ singh\\:\\ 0\\.0497502945358871\ \(0\)\
\-\ cs\\:\\ 0\\.0497502945358871\ \(0\)\
\-\ bipolar\\:\\ 0\\.04864496939233538\ \(0\)\
\-\ biopsy\\:\\ 0\\.048482518382526554\ \(0\)\
\-\ status\\:\\ 0\\.048267910873220236\ \(0\)\
\-\ liver\\:\\ 0\\.047713528246153804\ \(0\)\
\-\ 1mg\\:\\ 0\\.04771043029940072\ \(0\)\
\-\ jacobs\\:\\ 0\\.04771043029940072\ \(0\)\
\-\ mn\\:\\ 0\\.04771043029940072\ \(0\)\
\-\ 182\\:\\ 0\\.04690089571491841\ \(0\)\
\-\ tid\\:\\ 0\\.04690089571491841\ \(0\)\
\-\ readmitted\\:\\ 0\\.04690089571491841\ \(0\)\
\-\ leigh\\:\\ 0\\.04554808707162803\ \(0\)\
\-\ jakob\\:\\ 0\\.04554808707162803\ \(0\)\
\-\ sl\\:\\ 0\\.04554808707162803\ \(0\)\
\-\ spasms\\:\\ 0\\.044970268737764135\ \(0\)\
\-\ frontal\\:\\ 0\\.04451673785209516\ \(0\)\
\-\ creutzfeldt\\:\\ 0\\.044442761928076314\ \(0\)\
\-\ word\\:\\ 0\\.04395750270308239\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.04395750270308239\ \(0\)\
\-\ rj\\:\\ 0\\.04395750270308239\ \(0\)\
\-\ feed\\:\\ 0\\.04350822283514164\ \(0\)\
\-\ practical\\:\\ 0\\.04350822283514164\ \(0\)\
\-\ overload\\:\\ 0\\.04350822283514164\ \(0\)\
\-\ jm\\:\\ 0\\.04350822283514164\ \(0\)\
\-\ id\\:\\ 0\\.04350822283514164\ \(0\)\
\-\ monoxide\\:\\ 0\\.04308995328478594\ \(0\)\
\-\ pediatr\\:\\ 0\\.04308995328478594\ \(0\)\
\-\ decreased\\:\\ 0\\.042842503291152224\ \(0\)\
\-\ poisoning\\:\\ 0\\.04269868825065934\ \(0\)\
\-\ voice\\:\\ 0\\.04233115124631186\ \(0\)\
\-\ da\\:\\ 0\\.04233115124631186\ \(0\)\
\-\ tremor\\:\\ 0\\.04198462814123422\ \(0\)\
\-\ becoming\\:\\ 0\\.04198462814123422\ \(0\)\
\-\ roentgenol\\:\\ 0\\.04198462814123422\ \(0\)\
\-\ 250\\:\\ 0\\.04165684540307151\ \(0\)\
\-\ carbon\\:\\ 0\\.04165684540307151\ \(0\)\
\-\ dysarthria\\:\\ 0\\.04165684540307151\ \(0\)\
\-\ brisk\\:\\ 0\\.04134587960736896\ \(0\)\
\-\ assist\\:\\ 0\\.04134587960736896\ \(0\)\
\-\ thrive\\:\\ 0\\.04134587960736896\ \(0\)\
\-\ manner\\:\\ 0\\.04105008904829955\ \(0\)\
\-\ ad\\:\\ 0\\.04105008904829955\ \(0\)\
\-\ rings\\:\\ 0\\.040498572290914484\ \(0\)\
\-\ months\\:\\ 0\\.040259891083143734\ \(0\)\
\-\ shin\\:\\ 0\\.040240554463817246\ \(0\)\
\-\ interventions\\:\\ 0\\.040240554463817246\ \(0\)\
\-\ t2\\:\\ 0\\.03979279599080856\ \(0\)\
\-\ pontine\\:\\ 0\\.03952649435439213\ \(0\)\
\-\ 500\\:\\ 0\\.039306015370882574\ \(0\)\
\-\ revealing\\:\\ 0\\.039306015370882574\ \(0\)\
\-\ at\\:\\ 0\\.03918700243612529\ \(0\)\
\-\ person\\:\\ 0\\.03909327410874183\ \(0\)\
\-\ starting\\:\\ 0\\.03888774582052687\ \(0\)\
\-\ patterns\\:\\ 0\\.03888774582052687\ \(0\)\
\-\ block\\:\\ 0\\.03868895739278315\ \(0\)\
\-\ ajr\\:\\ 0\\.03868895739278315\ \(0\)\
\-\ trial\\:\\ 0\\.03849648078640027\ \(0\)\
\-\ thalami\\:\\ 0\\.03849648078640027\ \(0\)\
\-\ iron\\:\\ 0\\.03812894378205279\ \(0\)\
\-\ towards\\:\\ 0\\.0379532067275922\ \(0\)\
\-\ 1996\\:\\ 0\\.03745463793881244\ \(0\)\
\-\ 2011\\:\\ 0\\.037297161451981226\ \(0\)\
\-\ heel\\:\\ 0\\.037143672143109895\ \(0\)\
\-\ passed\\:\\ 0\\.037143672143109895\ \(0\)\
\-\ t2wi\\:\\ 0\\.03699397308373337\ \(0\)\
\-\ neurology\\:\\ 0\\.03656585380924599\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.03642961203368477\ \(0\)\
\-\ gradient\\:\\ 0\\.036296364826655415\ \(0\)\
\-\ appetite\\:\\ 0\\.036296364826655415\ \(0\)\
\-\ knees\\:\\ 0\\.03603834699955818\ \(0\)\
\-\ progressed\\:\\ 0\\.03591334249110582\ \(0\)\
\-\ away\\:\\ 0\\.03591334249110582\ \(0\)\
\-\ pons\\:\\ 0\\.03555308777456425\ \(0\)\
\-\ ocular\\:\\ 0\\.03543760801884794\ \(0\)\
\-\ nose\\:\\ 0\\.03499650415197035\ \(0\)\
\-\ biceps\\:\\ 0\\.0346855383562678\ \(0\)\
\-\ appeared\\:\\ 0\\.034200279131273874\ \(0\)\
\-\ no\\:\\ 0\\.03373772884720135\ \(0\)\
\-\ ataxia\\:\\ 0\\.033580213212716085\ \(0\)\
\-\ after\\:\\ 0\\.03355329646255456\ \(0\)\
\-\ dependent\\:\\ 0\\.033332729712977426\ \(0\)\
\-\ approach\\:\\ 0\\.033173180929469234\ \(0\)\
\-\ finger\\:\\ 0\\.03286615310329097\ \(0\)\
\-\ helpful\\:\\ 0\\.0327917656194743\ \(0\)\
\-\ am\\:\\ 0\\.032645674119781413\ \(0\)\
\-\ seen\\:\\ 0\\.03256253660066919\ \(0\)\
\-\ also\\:\\ 0\\.03253344820349774\ \(0\)\
\-\ degeneration\\:\\ 0\\.03216041489478749\ \(0\)\
\-\ alert\\:\\ 0\\.03183613953529911\ \(0\)\
\-\ dysphagia\\:\\ 0\\.03123540055458887\ \(0\)\
\-\ lab\\:\\ 0\\.03123540055458887\ \(0\)\
\-\ oriented\\:\\ 0\\.031178475217384625\ \(0\)\
\-\ 2003\\:\\ 0\\.03112207942587399\ \(0\)\
\-\ discharge\\:\\ 0\\.031010837701696548\ \(0\)\
\-\ urine\\:\\ 0\\.03095597303883895\ \(0\)\
\-\ giant\\:\\ 0\\.03084771116425184\ \(0\)\
\-\ double\\:\\ 0\\.03048333089200873\ \(0\)\
\-\ end\\:\\ 0\\.03043301936783265\ \(0\)\
\-\ volume\\:\\ 0\\.03038312193496983\ \(0\)\
\-\ reflexes\\:\\ 0\\.030235847392270074\ \(0\)\
\-\ improvement\\:\\ 0\\.030187540332939324\ \(0\)\
\-\ 34\\:\\ 0\\.030139615151588563\ \(0\)\
\-\ involves\\:\\ 0\\.030092065857882138\ \(0\)\
\-\ included\\:\\ 0\\.02990551255814483\ \(0\)\
\-\ hr\\:\\ 0\\.02972452885353465\ \(0\)\
\-\ discharged\\:\\ 0\\.029680114707128544\ \(0\)\
\-\ sensation\\:\\ 0\\.02963602357555425\ \(0\)\
\-\ few\\:\\ 0\\.029336050536933316\ \(0\)\
\-\ disorder\\:\\ 0\\.02925300124000465\ \(0\)\
\-\ started\\:\\ 0\\.029130522248718354\ \(0\)\
\-\ strength\\:\\ 0\\.028970973465210163\ \(0\)\
\-\ fibrosis\\:\\ 0\\.028970973465210163\ \(0\)\
\-\ point\\:\\ 0\\.028589558155215227\ \(0\)\
\-\ needed\\:\\ 0\\.02855270391485446\ \(0\)\
\-\ review\\:\\ 0\\.028479660815979427\ \(0\)\
\-\ cranial\\:\\ 0\\.0282656678755294\ \(0\)\
\-\ 17\\:\\ 0\\.028230725393381596\ \(0\)\
\-\ cortex\\:\\ 0\\.028161438880727856\ \(0\)\
\-\ be\\:\\ 0\\.02805766035880869\ \(0\)\
\-\ four\\:\\ 0\\.028025197105166634\ \(0\)\
\-\ features\\:\\ 0\\.027826408677422917\ \(0\)\
\-\ previously\\:\\ 0\\.0277615684457675\ \(0\)\
\-\ tube\\:\\ 0\\.027633932071040035\ \(0\)\
\-\ 21\\:\\ 0\\.027633932071040035\ \(0\)\
\-\ references\\:\\ 0\\.027571107634538513\ \(0\)\
\-\ stage\\:\\ 0\\.027539937880172713\ \(0\)\
\-\ there\\:\\ 0\\.027520720234522917\ \(0\)\
\-\ done\\:\\ 0\\.027508927562587677\ \(0\)\
\-\ al\\:\\ 0\\.027478075059006617\ \(0\)\
\-\ et\\:\\ 0\\.027090658012231972\ \(0\)\
\-\ additional\\:\\ 0\\.02680863023743748\ \(0\)\
\-\ progressive\\:\\ 0\\.026486651715964628\ \(0\)\
\-\ worsening\\:\\ 0\\.02640875980247712\ \(0\)\
\-\ matter\\:\\ 0\\.026331855973757888\ \(0\)\
\-\ extremities\\:\\ 0\\.026281123427749666\ \(0\)\
\-\ failure\\:\\ 0\\.02625591547513408\ \(0\)\
\-\ previous\\:\\ 0\\.026131424368373134\ \(0\)\
\-\ moderate\\:\\ 0\\.025961322920983\ \(0\)\
\-\ process\\:\\ 0\\.025937407687329495\ \(0\)\
\-\ http\\:\\ 0\\.025567063318324545\ \(0\)\
\-\ hospital\\:\\ 0\\.025544651078864094\ \(0\)\
\-\ greater\\:\\ 0\\.025477907242869476\ \(0\)\
\-\ throughout\\:\\ 0\\.02543381611129518\ \(0\)\
\-\ abnormality\\:\\ 0\\.025154784384928096\ \(0\)\
\-\ reported\\:\\ 0\\.02490814004414565\ \(0\)\
\-\ cortical\\:\\ 0\\.024828105827420385\ \(0\)\
\-\ very\\:\\ 0\\.02480826127985046\ \(0\)\
\-\ muscle\\:\\ 0\\.024556024738810352\ \(0\)\
\-\ 24\\:\\ 0\\.02451813396628346\ \(0\)\
\-\ identified\\:\\ 0\\.02451813396628346\ \(0\)\
\-\ then\\:\\ 0\\.02448047854168776\ \(0\)\
\-\ extension\\:\\ 0\\.02448047854168776\ \(0\)\
\-\ effect\\:\\ 0\\.024259329260884196\ \(0\)\
\-\ involving\\:\\ 0\\.024223242821779824\ \(0\)\
\-\ labs\\:\\ 0\\.023959231416468788\ \(0\)\
\-\ sign\\:\\ 0\\.023942032812396905\ \(0\)\
\-\ presentation\\:\\ 0\\.023806172698447415\ \(0\)\
\-\ recent\\:\\ 0\\.023415957357660718\ \(0\)\
\-\ showed\\:\\ 0\\.023034542047665783\ \(0\)\
\-\ white\\:\\ 0\\.02281670410269483\ \(0\)\
\-\ several\\:\\ 0\\.02268966212022918\ \(0\)\
\-\ found\\:\\ 0\\.0223766013511016\ \(0\)\
\-\ mr\\:\\ 0\\.0223766013511016\ \(0\)\
\-\ examination\\:\\ 0\\.02212964850949882\ \(0\)\
\-\ clinical\\:\\ 0\\.021916907247358074\ \(0\)\
\-\ diffuse\\:\\ 0\\.021687650929363995\ \(0\)\
\-\ brain\\:\\ 0\\.02155878126051965\ \(0\)\
\-\ treated\\:\\ 0\\.021535641904682525\ \(0\)\
\-\ loss\\:\\ 0\\.021069065294996064\ \(0\)\
\-\ for\\:\\ 0\\.02096351884903074\ \(0\)\
\-\ changes\\:\\ 0\\.02090035864891646\ \(0\)\
\-\ level\\:\\ 0\\.0208899687511387\ \(0\)\
\-\ all\\:\\ 0\\.0205862740138056\ \(0\)\
\-\ include\\:\\ 0\\.02057640826082369\ \(0\)\
\-\ two\\:\\ 0\\.020537105018664528\ \(0\)\
\-\ been\\:\\ 0\\.02014828898633632\ \(0\)\
\-\ significant\\:\\ 0\\.019967305281726137\ \(0\)\
\-\ one\\:\\ 0\\.019800235139205487\ \(0\)\
\-\ high\\:\\ 0\\.019654556658817834\ \(0\)\
\-\ than\\:\\ 0\\.019603965234188347\ \(0\)\
\-\ more\\:\\ 0\\.018989616512901878\ \(0\)\
\-\ increased\\:\\ 0\\.01870069482802921\ \(0\)\
\-\ into\\:\\ 0\\.018383582831139413\ \(0\)\
\-\ noted\\:\\ 0\\.018335711711469044\ \(0\)\
\-\ man\\:\\ 0\\.01830852554990519\ \(0\)\
\-\ without\\:\\ 0\\.018241088771474633\ \(0\)\
\-\ imaging\\:\\ 0\\.01817439388684253\ \(0\)\
\-\ other\\:\\ 0\\.017959365836598226\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01792744104523975\ \(0\)\
\-\ were\\:\\ 0\\.01782639697505544\ \(0\)\
\-\ it\\:\\ 0\\.017702415069940153\ \(0\)\
\-\ have\\:\\ 0\\.01727596951852129\ \(0\)\
\-\ had\\:\\ 0\\.017230386567917328\ \(0\)\
\-\ findings\\:\\ 0\\.017067963354670836\ \(0\)\
\-\ contrast\\:\\ 0\\.016803041411271712\ \(0\)\
\-\ presents\\:\\ 0\\.01663607722389998\ \(0\)\
\-\ which\\:\\ 0\\.01572511047218461\ \(0\)\
\-\ that\\:\\ 0\\.015007607015911577\ \(0\)\
\-\ normal\\:\\ 0\\.014119895927535481\ \(0\)\
\-\ not\\:\\ 0\\.013652438350323391\ \(0\)\
\-\ an\\:\\ 0\\.013224319075836018\ \(0\)\
\-\ history\\:\\ 0\\.013212604088868008\ \(0\)\
\-\ mass\\:\\ 0\\.013209678875846488\ \(0\)\
\-\ are\\:\\ 0\\.013122572436693953\ \(0\)\
\-\ left\\:\\ 0\\.011796922746689142\ \(0\)\
\-\ right\\:\\ 0\\.011465605198429514\ \(0\)\
\-\ on\\:\\ 0\\.010444577438174448\ \(0\)\
